AmerisourceBergen Q3 revenue $66.9B, EPS beat; raises FY guidance; to become Cencora

Cencora, Inc.

2023-Q3 EPS reported $6.80 revenue$193,251,080,000

Revenue $66.9B (+11.5% YoY); GAAP EPS $2.35 vs $1.92; adjusted EPS $2.92 vs $2.62.
Adjusted EPS guidance raised to $11.85-$11.95 from $11.70-$11.90 for fiscal 2023.
Company to rename to Cencora and trade under ticker 'COR' on NYSE effective Aug 30, 2023.
CEO cited strong performance and strategic investment in OneOncology during quarter.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Cencora, Inc. reported fiscal year 2023 third quarter ended June 30, 2023 results: revenue $66.9B, net income $480M, EPS $2.35. Guidance raised.

Period: fiscal year 2023 third quarter ended June 30, 2023
Revenue: $66.9B
Net income: $480M
EPS: $2.35
Guidance: raised
Result: reported results

Exact text from the filing

Third Quarter Fiscal Year 2023 Summary Results GAAP Adjusted (Non-GAAP) Revenue $66.9B $66.9B Gross Profit $2.3B $2.2B Operating Expenses $1.6B $1.4B Operating Income $670M $822M Interest Expense, Net $58M $58M Effective Tax Rate 21.3% 21.5% Net Income Attributable to AmerisourceBergen Corporation $480M $596M Diluted Earnings Per Share $2.35 $2.92

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Cencora, Inc. filing history →

Source: SEC EDGAR

accession 0001140859-23-000113

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.